Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.

× No keyword cloud information.

8 in total

1. Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors: Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal: Can J Infect Dis Med Microbiol Date: 2012 Impact factor: 2.471

2. Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

Authors: Raymond S W Tsang; Averil M Henderson; Marissa L Cameron; Shaun D Tyler; Shari Tyson; Dennis K S Law; Jan Stoltz; Wendell D Zollinger
Journal: J Clin Microbiol Date: 2007-04-18 Impact factor: 5.948

3. Questions and answers on immunization.

Authors: Susan Wootton; David Scheifele
Journal: Paediatr Child Health Date: 2007-04 Impact factor: 2.253

4. Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.

Authors: Tung Siu; Wrency Tang; Meenakshi Dawar; David M Patrick
Journal: Can J Public Health Date: 2008 Sep-Oct

8. Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).

Authors: Raymond Sw Tsang; Dennis Ks Law; Rita R Gad; Tim Mailman; Gregory German; Robert Needle
Journal: Can J Infect Dis Med Microbiol Date: 2015 Nov-Dec Impact factor: 2.471

8 in total

Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.

1. Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

2. Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

3. Questions and answers on immunization.

4. Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.

Review 5. The changing epidemiology of meningococcal disease in North America 1945-2010.

6. Increase in ST-11 serogroup W Neisseria meningitidis invasive meningococcal disease in Canada, 2016-2018.

7. Enhanced surveillance of invasive meningococcal disease in Canada, 2006-2011.

8. Characterization of invasive Neisseria meningitidis from Atlantic Canada, 2009 to 2013: With special reference to the nonpolysaccharide vaccine targets (PorA, factor H binding protein, Neisseria heparin-binding antigen and Neisseria adhesin A).